Julian Kött

29PUBLICATIONS
62CO-AUTHORS
German languageCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 08, 2026
Current skin of color representation in medical school dermatology education in Germany, Austria and Switzerland (DACH region).

|Oct 05, 2026
Poliosis predicts durable response to immune-checkpoint blockade in metastatic melanoma: a multicenter cohort study.

|Jul 01, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

|Feb 04, 2026
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.

Julian Kött, Nina Matthes, Alexander T Bauer

|Jan 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.

Glenn Geidel, Sabrina Bänsch, Laura Adam

|Dec 19, 2025
Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review.

Finn Abeck, Inga Hansen-Abeck, Julian Kött

Pageof 5

Frequent Collaborators

17 joint publications

Christoffer Gebhardt

10 joint publications

Glenn Geidel

8 joint publications

Stefan W Schneider

6 joint publications

Klaus Pantel